IL148654A0 - Parathyroid hormone analogues for the treatment of osteoporosis - Google Patents

Parathyroid hormone analogues for the treatment of osteoporosis

Info

Publication number
IL148654A0
IL148654A0 IL14865400A IL14865400A IL148654A0 IL 148654 A0 IL148654 A0 IL 148654A0 IL 14865400 A IL14865400 A IL 14865400A IL 14865400 A IL14865400 A IL 14865400A IL 148654 A0 IL148654 A0 IL 148654A0
Authority
IL
Israel
Prior art keywords
osteoporosis
treatment
parathyroid hormone
hormone analogues
analogues
Prior art date
Application number
IL14865400A
Other languages
English (en)
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of IL148654A0 publication Critical patent/IL148654A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14865400A 1999-09-22 2000-09-21 Parathyroid hormone analogues for the treatment of osteoporosis IL148654A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/406,813 US6316410B1 (en) 1999-09-22 1999-09-22 Parathyroid hormone analogues for the treatment of osteoporosis
PCT/CA2000/001083 WO2001021643A2 (en) 1999-09-22 2000-09-21 Parathyroid hormone analogues for the treatment of osteoporosis

Publications (1)

Publication Number Publication Date
IL148654A0 true IL148654A0 (en) 2002-09-12

Family

ID=23609550

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14865400A IL148654A0 (en) 1999-09-22 2000-09-21 Parathyroid hormone analogues for the treatment of osteoporosis

Country Status (13)

Country Link
US (1) US6316410B1 (cs)
EP (2) EP1881006A1 (cs)
JP (1) JP4620309B2 (cs)
CN (1) CN1377371A (cs)
AU (1) AU7398000A (cs)
BR (1) BR0016306A (cs)
CA (1) CA2384341A1 (cs)
CZ (1) CZ20021026A3 (cs)
IL (1) IL148654A0 (cs)
MX (1) MXPA02002977A (cs)
SK (1) SK4042002A3 (cs)
WO (1) WO2001021643A2 (cs)
ZA (1) ZA200202162B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ553800A0 (en) * 2000-02-10 2000-03-02 Cole, Martin Terence Improvements relating to smoke detectors particularily duct monitored smoke detectors
AU2003233286A1 (en) * 2002-05-16 2003-12-02 Theratechnologies Inc. Pth derivatives resistant to skin proteases
EP1551438A2 (en) * 2002-06-13 2005-07-13 Beth Israel Deaconess Medical Center, Inc. Analogs of parathyroid hormone and pth-related protein as bone anabolic agents
US7635477B2 (en) * 2002-07-25 2009-12-22 The General Hospital Corporation Parathyroid hormone receptor activation and stem and progenitor cell expansion
AU2003256839B2 (en) * 2002-07-25 2009-10-29 The General Hospital Corporation Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
AU2002951372A0 (en) * 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
WO2005007184A2 (en) * 2003-07-15 2005-01-27 National Research Council Of Canada Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells
EP1557176A1 (en) * 2004-01-26 2005-07-27 Ferring B.V. Treatment of bone metastases by means of PTH receptor agonists
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US8642564B2 (en) * 2004-08-25 2014-02-04 Aegis Therapeutics, Llc Compositions for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US9114069B2 (en) * 2004-08-25 2015-08-25 Aegis Therapeutics, Llc Antibacterial compositions for drug administration
US20110046059A1 (en) * 2005-09-06 2011-02-24 Zelos Therapeutics, Inc. Pharmaceutically acceptable formulations/compositions for peptidyl drugs
WO2007130113A2 (en) * 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
US7994129B2 (en) * 2005-11-10 2011-08-09 Michigan Technological University Methods of using black bear parathyroid hormone
WO2007133580A2 (en) * 2006-05-09 2007-11-22 Zelos Therapeutics, Inc. Use of pth (1-31) and optionally g-csf for hematopoietic stimulation
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
CA2659846A1 (en) * 2006-07-31 2008-02-07 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
WO2008048784A1 (en) * 2006-10-13 2008-04-24 Eli Lilly And Company Pegylated pth as pth receptor modulators and uses thereof
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
AU2009228093B2 (en) 2008-03-28 2014-08-07 Neurelis, Inc. Administration of benzodiazepine compositions
RU2384894C1 (ru) * 2008-10-27 2010-03-20 Леонид Борисович Лазебник Способ моделирования остеопороза
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP4085899A1 (en) 2011-06-14 2022-11-09 Neurelis, Inc. Administration of benzodiazepine
EP3122426B1 (en) 2014-03-28 2023-01-18 Duke University Treating breast cancer using selective estrogen receptor modulators
IL255189B2 (en) 2015-04-29 2024-04-01 Radius Pharmaceuticals Inc A combination of rad1901 and a cdk4/6 inhibitor for use in treating cancer
CN105440126B (zh) * 2015-12-31 2019-10-25 南京工业大学 治疗骨质疏松的α-螺旋多肽及其制备方法与应用
RS65694B1 (sr) 2017-01-05 2024-07-31 Radius Pharmaceuticals Inc Polimorfni oblici rad1901-2hcl
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形形態
JOP20210218A1 (ar) 2019-02-12 2023-01-30 Radius Pharmaceuticals Inc عمليات ومركبات

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US6110892A (en) * 1994-06-20 2000-08-29 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
DE19508672A1 (de) 1995-03-10 1996-09-12 Boehringer Mannheim Gmbh Neue cyclische Parathormonfragmente, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5717062A (en) * 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
KR100500859B1 (ko) 1996-08-02 2005-07-14 내셔날 리서치 카운실 오브 캐나다 골다공증 치료를 위한 부갑상선 호르몬 유사체
EA002819B1 (ru) 1997-05-14 2002-10-31 Авентис Фармасьютикалз Продактс Инк. Циклическое пептидное соединение и его применение, бициклопептидное соединение, пептидное соединение и его применение, фармацевтическая композиция

Also Published As

Publication number Publication date
EP1881006A1 (en) 2008-01-23
SK4042002A3 (en) 2002-12-03
JP4620309B2 (ja) 2011-01-26
JP2003510256A (ja) 2003-03-18
WO2001021643A2 (en) 2001-03-29
AU7398000A (en) 2001-04-24
CZ20021026A3 (cs) 2003-05-14
CA2384341A1 (en) 2001-03-29
CN1377371A (zh) 2002-10-30
WO2001021643A3 (en) 2001-10-25
US6316410B1 (en) 2001-11-13
ZA200202162B (en) 2003-08-27
MXPA02002977A (es) 2004-09-06
EP1214348A2 (en) 2002-06-19
BR0016306A (pt) 2003-04-08

Similar Documents

Publication Publication Date Title
IL148654A0 (en) Parathyroid hormone analogues for the treatment of osteoporosis
LT99010A (en) Parathyroid hormone analogues for the treatment of osteoporosis
PL339449A1 (en) Treatment of bone fractures involving the use of pthrp analogues
IL130794A0 (en) Analogs of parathyroid hormone
ZA988886B (en) Formulation for treatment of osteoporosis
HUP9900604A3 (en) New peptide compounds that are analogues of the glucagon-like p
HUP0202812A3 (en) Novel bicyclonucleoside analogues
FI990126L (fi) Paratyreoideahormonianalogeja osteoporoosin hoitoon
AU5003401A (en) Hormone replacement therapy
AU6152200A (en) Azolylbenzamides and analogues and their use for treating osteoporosis
ZA984077B (en) Peptide parathyroid hormone analogs
SI1506041T1 (sl) Ibandronska kislina za zdravljenje in preprecevanje osteoporoze
ZA200308027B (en) Hormone replacement therapy
IL159000A0 (en) Quinazoline derivatives which promote the release of parathyroid hormone
AU2003239869A8 (en) Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
EP0779812A4 (en) METHOD FOR TREATING OSTEOPOROSIS USING BONE-ACTIVE PHOSPHONATES AND PARATHORMONE
IL147862A0 (en) Process and intermediates for the preparation os isoxazolecaroxamides and analogues
ZA200304047B (en) Analogues of GLP-1.
HUP0203741A3 (en) Treatment of osteoporosis
IL120955A0 (en) Treatment of osteoporosis
ZA9861B (en) Analogs of parathyroid hormone
SI1175904T1 (sl) Alendronat za rabo pri zdravljenju osteoporoze
ZA961859B (en) Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
SI1021194T1 (en) New improved formulation for treatment of osteoporosis
AR001227A1 (es) Métodos para el tratamiento de la osteoporosis utilizando compuestos de estrogeno y hormona paratiroidea